As of 2025-09-16, the Intrinsic Value of Ikena Oncology Inc (IKNA) is -5.10 USD. This IKNA valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.43 USD, the upside of Ikena Oncology Inc is -456.71%.
Based on its market price of 1.43 USD and our intrinsic valuation, Ikena Oncology Inc (IKNA) is overvalued by 456.71%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.10 - -5.10 | -5.10 | -456.71% |
| P/E | (6.09) - (10.73) | (7.62) | -632.7% |
| DDM - Stable | (3.10) - (9.08) | (6.09) | -525.7% |
| DDM - Multi | (2.30) - (5.38) | (3.24) | -326.4% |
| Market Cap (mil) | 170.97 |
| Beta | 0.80 |
| Outstanding shares (mil) | 119.56 |
| Enterprise Value (mil) | 170.97 |
| Market risk premium | 4.60% |
| Cost of Equity | 10.70% |
| Cost of Debt | 5.00% |
| WACC | 7.18% |